- Else’s (BABY) toddler products are being rolled out into over 1,000 CVS Pharmacy HealthHUB locations
- This is the company’s first placement with a major U.S. drug store retailer
- The partnership will expand brand awareness to millions of new customers in 35 states across the U.S.
- Else Nutrition develops plant-based food and nutrition products for infants, toddlers, children and adults
- Else Nutrition (BABY) is up by 2.53 per cent trading at $0.81 per share
Else’s (BABY) toddler products are being rolled out into over 1,000 CVS Pharmacy HealthHUB locations.
The milestone represents Else’s first placement with a major U.S. drug store retailer as well as its largest national customer.
The deal covers 35 states across the U.S. and will provide the company with exposure to millions of new households.
The company believes that its minimally processed, whole-plant nutrition products align with CVS’ health-conscious clientele.
“Being available for purchase in CVS is a strategic milestone for Else in the North American market,” said Hamutal Yitzhak, Else’s Co-Founder and CEO. “Adding an additional 1,000 doors are a material increase in our footprint in the U.S. market, and we expect the added credibility and customer reach of CVS to compound the growth effect of these new doors.”
Else Nutrition develops plant-based food and nutrition products for infants, toddlers, children and adults.
Else Nutrition (BABY) is up by 2.53 per cent trading at $0.81 per share as of 10:26 am EST.
